GlassScriptPhysician profile
Johann Georg Ohly
NPI 1336348820
$4,199.12
in general payments reported to CMS, 2019-2025
30 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $235 · 2021: $853 · 2022: $571 · 2023: $644 · 2024: $842 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,047.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,109.42 | 2020-2025 | Clareon, Clareon Panoptix Pro, Centurion |
| Abbvie INC. | $392.48 | 2022-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $342.04 | 2019-2024 | Tecnis Iol, Tecnis Simplicity |
| Carl Zeiss Meditec USA, INC. | $240.84 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $231.05 | 2022-2025 | Vyzulta, Miebo, Envista Mx60 Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $219.52 | 2019-2021 | |
| Allergan, INC. | $189.43 | 2019-2022 | |
| Oyster Point Pharma, INC. | $137.99 | 2022-2025 | Tyrvaya, Ryzumvi |
| Rxsight INC | $135.25 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Coopervision INC. | $126.09 | 2019-2022 | |
| Dompe US, INC. | $115.76 | 2022-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $114.52 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $110.88 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $98.11 | 2019-2022 | |
| Biotissue Holdings INC. | $83.94 | 2019-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $73.22 | 2022-2025 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $65.87 | 2019-2020 | |
| The Cameron-Ehlen Group, INC. | $57.06 | 2021-2023 | Tecnis Iol, Healon Pro, Tecnis Simplicity |
| Harrow Eye, LLC | $52.12 | 2023-2024 | Iheezo |
| Horizon Therapeutics Plc | $46.94 | 2019-2020 | |
| Sight Sciences, INC. | $44.97 | 2021-2022 | |
| Ivantis, INC | $43.57 | 2021 | |
| Glaukos Corporation | $34.95 | 2024 | Idose |
| Mallinckrodt Hospital Products INC. | $34.80 | 2025 | Acthar |
| Lumenis, INC | $21.58 | 2021 | |
| Spark Therapeutics, INC. | $18.42 | 2022 | |
| Genzyme Corporation | $17.91 | 2019 | |
| Kerecis Limited | $15.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Lombart Brothers, INC. | $13.21 | 2023 | Opd-III |
| Ocular Therapeutix, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johann Ohly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.